These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Visualization of Cholesterol Crystals Liberated From a Diseased Saphenous Vein Coronary Bypass Graft. Kobayashi T; Higuchi Y; Komatsu S; Yutani C; Hirayama A; Kodama K JACC Cardiovasc Interv; 2020 Jun; 13(11):e105-e106. PubMed ID: 32417089 [No Abstract] [Full Text] [Related]
30. Drug eluting stents versus bare metal stents in the treatment of saphenous vein graft disease: a systematic review and meta-analysis. Testa L; Agostoni P; Vermeersch P; Biondi-Zoccai G; Van Gaal W; Bhindi R; Brilakis E; Latini RA; Laudisa ML; Pizzocri S; Lanotte S; Brambilla N; Banning A; Bedogni F EuroIntervention; 2010 Sep; 6(4):527-36. PubMed ID: 20884442 [TBL] [Abstract][Full Text] [Related]
31. A new dedicated ultrashort steerable balloon for side branch ostial dilatation. Secco GG; Di Mario C Catheter Cardiovasc Interv; 2011 Feb; 77(3):363-6. PubMed ID: 21328681 [TBL] [Abstract][Full Text] [Related]
32. Thrombus removal prior to recanalization in vein graft occlusion intervention. Fung RC; Jim MH Asian Cardiovasc Thorac Ann; 2019 Feb; 27(2):121-123. PubMed ID: 29719982 [TBL] [Abstract][Full Text] [Related]
33. Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry. Brilakis ES; Wang TY; Rao SV; Banerjee S; Goldman S; Shunk K; Kar B; Holmes DR; Dai D; Chin CT; Harding TM; Roe MT JACC Cardiovasc Interv; 2010 Oct; 3(10):1068-73. PubMed ID: 20965466 [TBL] [Abstract][Full Text] [Related]
34. The quest for optimal interventional strategy in saphenous vein graft interventions--are we there yet? Gupta S; Cigarroa JE Catheter Cardiovasc Interv; 2012 Dec; 80(7):1118-9. PubMed ID: 23225650 [No Abstract] [Full Text] [Related]
35. Outcomes after implantation of the TAXUS paclitaxel-eluting stent in saphenous vein graft lesions: results from the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) program. Brilakis ES; Lasala JM; Cox DA; Berger PB; Bowman TS; Starzyk RM; Dawkins KD JACC Cardiovasc Interv; 2010 Jul; 3(7):742-50. PubMed ID: 20650436 [TBL] [Abstract][Full Text] [Related]
36. Distal embolization after net protective stent (MGUARD) implantation in a degenerated saphenous vein graft lesion. Yassin I; Thuesen L Catheter Cardiovasc Interv; 2010 Mar; 75(4):639-41. PubMed ID: 20091812 [TBL] [Abstract][Full Text] [Related]
37. Hinge motion and excessive negative remodeling as a cause of early saphenous vein graft failure. Kume T; Okura H; Fukuhara K; Koyama T; Nezuo S; Neishi Y; Hayashida A; Kawamoto T; Tanemoto K; Yoshida K JACC Cardiovasc Interv; 2013 Mar; 6(3):e15-6. PubMed ID: 23517849 [No Abstract] [Full Text] [Related]
38. Non-ST-segment elevation myocardial infarction related to vulnerable neoatheroma in bare-metal stents 2 years after percutaneous coronary intervention of a coronary saphenous vein graft. Roleder T; Wańha W; Smolka G; Ochała A; Wojakowski W JACC Cardiovasc Interv; 2014 Aug; 7(8):e95-6. PubMed ID: 25086848 [No Abstract] [Full Text] [Related]
39. Current percutaneous treatment strategies for saphenous vein graft disease. Marmagkiolis K; Grines C; Bilodeau L Catheter Cardiovasc Interv; 2013 Sep; 82(3):406-13. PubMed ID: 22777812 [TBL] [Abstract][Full Text] [Related]
40. Drug-eluting versus bare-metal stents for saphenous vein graft lesions. Conte SM; Florisson DS; De Bono JA; Vale PR Intern Med J; 2019 Dec; 49(12):1534-1537. PubMed ID: 31808253 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]